Rates of multiple myeloma (MM), the second most common blood cancer in the United States, are increasing and are twice as ...
Rates of multiple myeloma (MM), the second most common blood cancer in the United States, are increasing and are twice as ...
In A Nutshell Men have double the odds of presenting with stage III multiple myeloma compared to women, even after accounting ...
Study identifies several clinical features involved.Rates of multiple myeloma (MM), the second most common blood cancer in ...
Experts discuss the critical challenges in accessing innovative treatments for relapsed refractory multiple myeloma, ...
Explore the transformative potential of bispecific antibodies in multiple myeloma, offering hope for improved patient ...
Scientists at the Icahn School of Medicine at Mount Sinai, in partnership with the Multiple Myeloma Research Foundation (MMRF ...
To Jagannath, cure means long periods of disease-free survival as defined by minimal residual disease (MRD) criteria, 10 -5 ...
Multiple myeloma is a chronic (long-term) blood cancer that affects plasma cells made in the bone marrow, which is spongy tissue found inside bones. While people with multiple myeloma can live for ...
Discover the latest breakthroughs in multiple myeloma treatment, including CAR T-cell therapies and promising new options for ...
A new study maps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in ...
Longer-term results from the BENEFIT trial show sustained minimal residual disease negativity in newly diagnosed, ...